Health Care·Health Care Technology·$26.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.12 | N/A | +44.58% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.12 | N/A | +44.58% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook on earnings performance. However, they did not provide specific guidance for future quarters.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They emphasized the importance of maintaining growth in a competitive market.
Veeva's earnings report shows a strong performance in EPS, significantly exceeding expectations, which likely contributed to the stock's 5.49% increase. The lack of revenue data may raise questions among investors, but the positive EPS surprise suggests the company is managing costs effectively. Overall, the market reacted favorably, indicating confidence in Veeva's ability to generate profits.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
MATADOR RES CO
Mar 2, 2015